Mater H Mahnashi1, Bandar A Alyami2, Yahya S Alqahtani3, Muhammad Saeed Jan4, Umer Rashid5, Abdul Sadiq6, Ali O Alqarni7. 1. Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia. Electronic address: matermaha@gmail.com. 2. Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia. Electronic address: alyamibandar1@gmail.com. 3. Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran, Saudi Arabia. Electronic address: yahyasalqahtani0@gmail.com. 4. Department of Pharmacy, University of Swabi, Swabi, KP, Pakistan. Electronic address: saeedjanpharmacist@gmail.com. 5. Department of Chemistry, COMSATS University Islamabad, Abbottabad Campus, 22060 Abbottabad, Pakistan. Electronic address: umerrashid@cuiatd.edu.pk. 6. Department of Pharmacy, Faculty of Biological Sciences, University of Malakand, Chakdara, 18000 Dir (L), KP, Pakistan. Electronic address: sadiquom@yahoo.com. 7. Department of Medicinal Chemistry, School of Pharmacy, Najran University, Saudi Arabia.
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Members of Orchidaceae family has a long history in herbal and Chinese medicines. Members of this family are most commonly famous in the management of inflammation and analgesia in folk medicine. Habenaria digitata, an unexplored specie of Orchidaceae is found in North areas of Pakistan and is used by the local population for the management of analgesia and inflammation. AIM OF THE STUDY: Based on the effective outcomes of the natural products as alternative therapies, we have evaluated Habenaria digitata for the management of analgesia and inflammation. The aim of the designed project is to provide a scientific basis of using this plant for the management of analgesia and inflammation. MATERIALS AND METHODS: The H. digitata crude extract (Hd.Cr) and subfractions, i.e. n-hexane (Hd.Hex), chloroform (Hd.Chf), ethyl acetate (Hd.EtAc), n-butanol (Hd.Bt) and aqueous (Hd.Aq) were used. The GC-MS analysis was used for the identification of phytochemicals. The plants samples were subjected to cyclooxygenase (COX 2) and lipoxygenase (5-LOX) enzymes assays. The hot plate model, acetic acid induced writhing and formalin induced paw licking models were used for in-vivo analgesic studies. The in-vivo anti-inflammatory potential was determined with carrageenan induced paw edema test. Molecular docking studies of the identified compounds were carried out by using Molecular Operating Environment (MOE, 2016.08). RESULTS: The GC-MS analysis confirmed sixty-five compounds in Hd.Cr. Among the fractions, Hd.Chf and Hd.EtAc displayed highest activities. The observed IC50 values were 21.30 and 32.39 μg/ml against COX 2 while 14.42and 16.40 μg/ml for 5-LOX respectively. The in-vivo inflammatory and analgesic studies were pre-requisited with acute toxicity tests. In carrageenan induced inflammation, Hd.Chf excelled the standard drug aspirin by giving 62.92% inhibition of paw edema at 4th h. Similarly, at highest concentration (75 mg/kg) of acetic acid induced analgesia, Hd.Chf was more potent than the standard drug. In formalin method, Hd.Chf exhibited 85.81% inhibition at phase-I and 74.15% at Phase-II. In hot plate model, Hd.Chf exhibited average reaction time of 10.90 at 15, 30, 45 and 60 min intervals. Docking studies supported our results and confirm the synergistic effects of phytochemicals. CONCLUSIONS: Our experimental results concluded that H. digitata contains several bioactive compounds. These bioactive compounds synergistically have therapeutic efficacy for the management of inflammation and analgesia. We have confirmed both of these potentials from the in-vitro and in-vivo experiments. Moreover, it is also obvious that the chloroform and ethyl acetate fractions are rich in these bioactive compounds. Specifically, the Hd.Chf is observed to be more practical in all the tested models of analgesia and inflammation. Computed binding energies of the compounds revealed that all the compounds have synergistic effect to prevent analgesia and inflammation.
ETHNOPHARMACOLOGICAL RELEVANCE: Members of Orchidaceae family has a long history in herbal and Chinese medicines. Members of this family are most commonly famous in the management of inflammation and analgesia in folk medicine. Habenaria digitata, an unexplored specie of Orchidaceae is found in North areas of Pakistan and is used by the local population for the management of analgesia and inflammation. AIM OF THE STUDY: Based on the effective outcomes of the natural products as alternative therapies, we have evaluated Habenaria digitata for the management of analgesia and inflammation. The aim of the designed project is to provide a scientific basis of using this plant for the management of analgesia and inflammation. MATERIALS AND METHODS: The H. digitata crude extract (Hd.Cr) and subfractions, i.e. n-hexane (Hd.Hex), chloroform (Hd.Chf), ethyl acetate (Hd.EtAc), n-butanol (Hd.Bt) and aqueous (Hd.Aq) were used. The GC-MS analysis was used for the identification of phytochemicals. The plants samples were subjected to cyclooxygenase (COX 2) and lipoxygenase (5-LOX) enzymes assays. The hot plate model, acetic acid induced writhing and formalin induced paw licking models were used for in-vivo analgesic studies. The in-vivo anti-inflammatory potential was determined with carrageenan induced paw edema test. Molecular docking studies of the identified compounds were carried out by using Molecular Operating Environment (MOE, 2016.08). RESULTS: The GC-MS analysis confirmed sixty-five compounds in Hd.Cr. Among the fractions, Hd.Chf and Hd.EtAc displayed highest activities. The observed IC50 values were 21.30 and 32.39 μg/ml against COX 2 while 14.42and 16.40 μg/ml for 5-LOX respectively. The in-vivo inflammatory and analgesic studies were pre-requisited with acute toxicity tests. In carrageenan induced inflammation, Hd.Chf excelled the standard drug aspirin by giving 62.92% inhibition of paw edema at 4th h. Similarly, at highest concentration (75 mg/kg) of acetic acid induced analgesia, Hd.Chf was more potent than the standard drug. In formalin method, Hd.Chf exhibited 85.81% inhibition at phase-I and 74.15% at Phase-II. In hot plate model, Hd.Chf exhibited average reaction time of 10.90 at 15, 30, 45 and 60 min intervals. Docking studies supported our results and confirm the synergistic effects of phytochemicals. CONCLUSIONS: Our experimental results concluded that H. digitata contains several bioactive compounds. These bioactive compounds synergistically have therapeutic efficacy for the management of inflammation and analgesia. We have confirmed both of these potentials from the in-vitro and in-vivo experiments. Moreover, it is also obvious that the chloroform and ethyl acetate fractions are rich in these bioactive compounds. Specifically, the Hd.Chf is observed to be more practical in all the tested models of analgesia and inflammation. Computed binding energies of the compounds revealed that all the compounds have synergistic effect to prevent analgesia and inflammation.
Authors: Abdul Sadiq; Mater H Mahnashi; Umer Rashid; Muhammad Saeed Jan; Mohammed Abdulrahman Alshahrani; Mohammed A Huneif Journal: Molecules Date: 2022-05-19 Impact factor: 4.927
Authors: Mohammed A Huneif; Seham M Alqahtani; Alqahtani Abdulwahab; Sultan A Almedhesh; Mater H Mahnashi; Muhammad Riaz; Najm Ur-Rahman; Muhammad Saeed Jan; Farhat Ullah; Muhammad Aasim; Abdul Sadiq Journal: Molecules Date: 2022-05-26 Impact factor: 4.927
Authors: Ali Khan; Aini Pervaiz; Bushra Ansari; Riaz Ullah; Syed Muhammad Mukarram Shah; Haroon Khan; Muhammad Saeed Jan; Fida Hussain; Mohammad Ijaz Khan; Ghadeer M Albadrani; Ahmed E Altyar; Mohamed M Abdel-Daim Journal: Molecules Date: 2022-06-24 Impact factor: 4.927
Authors: Mater H Mahnashi; Yahya S Alqahtani; Ali O Alqarni; Bandar A Alyami; Muhammad Saeed Jan; Muhammad Ayaz; Farhat Ullah; Umer Rashid; Abdul Sadiq Journal: BMC Complement Med Ther Date: 2021-10-27
Authors: Mater H Mahnashi; Yahya S Alqahtani; Bandar A Alyami; Ali O Alqarni; Mohammad Ahmed Alshrahili; Mahrous A Abou-Salim; Mohammed N Alqahtani; Sadaf Mushtaq; Abdul Sadiq; Muhammad Saeed Jan Journal: Evid Based Complement Alternat Med Date: 2022-03-31 Impact factor: 2.629
Authors: Mater H Mahnashi; Bandar A Alyami; Yahya S Alqahtani; Ali O Alqarni; Muhammad Saeed Jan; Fida Hussain; Rehman Zafar; Umer Rashid; Muhammad Abbas; Muhammad Tariq; Abdul Sadiq Journal: Oxid Med Cell Longev Date: 2022-02-27 Impact factor: 7.310
Authors: Saeed Ali Alsareii; Nasser A N Alzerwi; Mansour Yousef AlAsmari; Abdulrahman Manaa Alamri; Mater H Mahnashi; Ibrahim Ahmed Shaikh Journal: Evid Based Complement Alternat Med Date: 2022-04-13 Impact factor: 2.650
Authors: Rehman Zafar; Humaira Naureen; Muhammad Zubair; Khadija Shahid; Muhammad Saeed Jan; Samar Akhtar; Hammad Ahmad; Wajeeha Waseem; Ali Haider; Saqib Ali; Muhammad Tariq; Abdul Sadiq Journal: Drug Des Devel Ther Date: 2021-06-21 Impact factor: 4.162